SEC Form 4 · accession 0001437749-16-026483
Impax Laboratories, LLC · IPXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Schlossberg
Officer — SVP and General Counsel
Period of report
Feb 26, 2016
Accepted (ET)
Mar 1, 2016 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001003642
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2016 | F | 1,931 | $33.27 | D | 71,657 | D | |
| Common Stock | Feb 26, 2016 | A | 21,852 | $0.00 | A | 93,509 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $33.27 | Feb 26, 2016 | A | 52,801 | A | — | Feb 26, 2026 | Common Stock | 52,801 | 52,801 | D |
Explanation of responses
- F1These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- F2The option vests in four equal installments beginning on February 26, 2017, which is the first anniversary of the grant date.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.